Regulation & Compliance

As Akebia heads to a major conference, investors watch its Vafseo launch, new rare disease pipeline, and path to profitability. Here's what's at stake.

A novel drug delivery system could revolutionize Alzheimer's treatment, and Acumen Pharmaceuticals is leading the charge with its targeted therapy.

A new report reveals 87% of firms use AI in customer education, but a dangerous lack of strategy and governance threatens quality, security, and ROI.

With burnout and financial woes plaguing healthcare, Altera Digital Health bets on advanced AI to ease burdens and restore the human touch at HIMSS26.

As AI reshapes software, Tricentis is taking its Transform conference global, pushing a new paradigm of 'agentic quality engineering.' Here's what it means.

As shadow AI and autonomous agents create huge risks, Teramind's new platform offers total visibility to help firms innovate without sacrificing security.

As SIGA prepares to unveil its 2025 financials, investors are focused on the future of its Tpoxx contracts and its role in global biodefense strategy.

A significant order for critical Tomahawk missile parts sends Mobix Labs' stock soaring, highlighting the firm's key role in a surging defense market.

After a kidney trial setback, CalciMedica's lead drug Auxora shows strong promise for acute pancreatitis, but a tight cash runway looms over its future.

A new report shows fraud fears in private credit are soaring, fueled by AI and bankruptcies, but data reveals a different story for secured lenders.

A novel inhaled RNA therapy for a specific group of cystic fibrosis patients gains EMA fast-track status, promising accelerated access to new treatment.

With over 100% revenue growth, Ada's success highlights a major industry shift from AI experiments to fully integrated agentic customer experience models.

A major renewal with a 30M-client bank highlights the industry's shift to biometrics, boosting BIO-key's finances and solidifying its market niche.

At QuanCon 2026, Quantexa unveiled a landmark partnership with Moody’s, positioning Decision Intelligence as the core of next-gen AI organizations.

K2 International launches a professional indemnity unit led by 40-year veteran Richard Smart, targeting the global market from London with Lloyd's backing.

Chicago attorney Eirene N. Salvi's Crain's honor highlights a career balancing record-setting verdicts with profound community service and judicial reform.

The trans-pacific merger between US BioTek and Australia's NutriPATH creates a major new force in functional medicine, promising expanded global access.

Little Rapids Corporation merges its paper and packaging arms into Rapids Paper + Packaging, a new entity aimed at tackling plastic waste with integrated solutions.

Publishing giant convenes leaders to define standards for adaptive knowledge, tackling IP, trust, and the very future of reading in the age of AI.

A federal policy loophole is diverting billions from struggling rural providers to wealthy urban hospitals, threatening care for millions of Americans.